Pharma Mirror

FEBRUARY 11, 2021

In late 2018, National OncoVenture (NOV), a government-funded virtual oncology drug development program in Korea, approached Samsung Biologics for the development of EU101(NOV1801), an anti-4-1BB therapeutic monoclonal antibody provided by Eutilex (KOSDAQ:263050). We are extremely glad to.

Immunity 52

Immunity Immunization Drug Development 52

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives.

Drug Development 52

Drug Development Immunization Immunity Hospitals 52

pharmaphorum

JUNE 8, 2021

All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. Chemotherapy still accounted for 72.6% of the oncology market in China in 2019, compared to 17.1%

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

pharmaphorum

SEPTEMBER 1, 2020

George Merck on the cover of Time magazine. Thalidomide and the development of drug safety regulation and monitoring. Fordian methods enabled more rational methods of mass production, and increasing understanding of biology and chemistry enabled drug candidates to be chosen systematically rather than discovered serendipitously.

Diabetes 145

Diabetes Immunity Immunization Vaccines 145